Patient info

HyperiTab – patient leaflet, side effects, dosage

Patient leaflet - Hyperitab

1. WHAT IS HYPERITAB AND WHAT IT IS USED FOR

This product is a traditional herbal medicinal product containing aerial parts of St. John's Wort as a dry extract. Each film-coated tablet contains 313mg of extract (as dry extract) from St. John’s Wort aerial parts (Hypericum perforatum L.) (equivalent to 1000mg to 1500mg of St. John’s Wort). Extraction solvent: Methanol 80% v/v.

HyperiTab is a traditional herbal medicinal product used to relieve the symptoms of slightly low mood and mild anxiety based on traditional use only.

2. BEFORE YOU TAKE HYPERITAB

DO NOT TAKE THIS PRODUCT IF

  • you are under 18 years of age;
  • you are pregnant or breast-feeding;

  • you are allergic to any of the ingredients;
  • your skin is exceptionally sensitive to sunlight (photosensitive);
  • you are having light treatment (phototherapy) for any condition; or
  • you are suffering from depression.

Suffering from depression?

Symptoms of depression include feelings of helplessness and hopeless-ness, loss of interest in daily activities, appetite or weight changes, sleep changes, loss of energy and difficulty concentrating. If your doctor has told you that you are suffering from depression do not use this product. If you think that you may be suffering from depression you should tell your doctor.

While you are taking this product

  • avoid excessive sunbathing or the use of sunbeds/solariums.
  • stop taking these tablets at least 10 days prior to any surgery.

Information about the ingredients in this product

This product contains lactose. Tell your doctor before taking this product if you have an intolerance to some sugars.

Driving and using machines

HyperiTab may make you feel dizzy or sleepy. If affected do not drive or use machines.

Taking Other Medicines

HyperiTab can affect the way some medicines work and reduce their effectiveness. Please tell your doctor or pharmacist if you are taking or have recently taken any other medicines including medicines obtained without a prescription. It is important that you do not take HyperiTab if you are using any of the medicines listed in the table below.

DO NOT TAKE THIS PRODUCT IF YOU ARE TAKING ANY OF THE FOLLOWING MEDICINES
All hormonal contraceptivesThe birth control ‘Pill’, emergency contraception (also known as the morning-after pill), hormonal implants, creams, patches, intra-uterine devices with hormones.
All medicines for depression/anxietyAmitriptyline, clomipramine, moclobemide, citalopram, escitalopram, fluoxetine, fluvoxamine, paroxetine, sertraline, duloxetine, venlafaxine.
All hormonal replacement therapy (HRT) treatmentsHRT tablets, transdermal patches, gels, vaginal rings.
All medicines for thinning the blood (anticoagulants)Warfarin, acenocoumarol.
All medicines for epilepsyCarbamazepine, phenobarbitone, phenytoin, primidone, sodium valproate.
All immunosuppressant medicinesCiclosporin, tacrolimus.
All medicines for HIV infectionsAmprenavir, atazanavir, darunavir, fosamprenavir, indinavir, lopinavir, nelfinavir, ritonavir, saquinavir, tipranavir, efavirenz, nevirapine, delavirdine.
Medicines for cholesterolSimvastatin, atorvastatin.
Medicines for cancerIrinotecan, dasatinib, erlotinib, imatinib, sorafenib, sunitinib, etoposide, mitotane.
Medicines for heart diseaseDigoxin, ivabradine, amiodarone.
Medicines for migrainesAlmotriptan, eletriptan, frovatriptan, naratriptan, rizatriptan, sumatriptan and zolmitriptan.
Medicines for high blood pressureAmlodipine, nifedipine, verapamil, felodipine.
Medicines for regulating moodLithium
Thyroid hormoneThyroxine

Package Leaflet: Information For The User

St John's Wort Extract 313mg

Digestive upsets:

  • Feeling sick
  • Diarrhoea or constipation
  • Indigestion
  • Loss of appetite

Allergic skin reactions:

  • Rash
  • Red itchy spots
  • Itching

Frequency of these effects is not known

Fatigue (tiredness) and restlessnes

These include headaches, nerve pain or tingling (neuropathy), anxiety, dizziness, mania. Also sunburn like reactions in skin exposed to strong ultra-violet (UV) irradiation (e.g. sun solarium) have been reported, particularly in fair-skinned individuals.

Other side effects

HyperiTab may also affect the following medicines. Therefore do not take this product with these medicines unless a doctor or pharmacist has said it is safe to do so:

  • Fentanyl, propofol, sevoflurane, midazolam (anaesthetics / pre-operative medicines)
  • Tramadol (an analgesic)
  • Erythromycin, clarithromycin, telithromycin (antibiotics)
  • Itraconazole, voriconazole (antifungals)
  • Artemether and lumefantrine (antimalarials)
  • Rasagiline (anti-Parkinson’s medicine)
  • Aripiprazole (antipsychotic medicine)
  • Buspirone (an anxiolytic)
  • Aprepitant (used to treat post-operative vomiting)
  • Butobarbital and Phenobarbital (barbiturates)
  • Methyl phenidate (a central nervous system or CNS stimulant)
  • Examestane (hormone antagonist)
  • Eplerenone (diuretic)
  • Lansoprazole and omeprazole (proton pump inhibitors)
  • Theophylline (bronchodilator)
  • Gliclazide (antidiabetic medicine)

You must speak to a doctor or qualified healthcare practitioner if your symptoms worsen, or do not improve after 6 weeks.

3. HOW TO TAKE HYPERITAB

Adults and the elderly

Take 1-2 tablets daily.

Swallow the tablets whole with some water. Do not chew the tablets. Not recommended for children or adolescents under 18 years of age.

Do not take more than label/leaflet tells you.

If you take more HyperiTab than you should

If you take more than the recommended dose, speak to your doctor, pharmacist or qualified healthcare practitioner and take this leaflet with you.

If you forget to take this product

Continue to take your usual dose at the usual time, it does not matter if you have missed a dose. Do not take a double dose to make up the missed.

If you have any further questions on the use of this product ask your doctor or pharmacist.

4. POSSIBLE SIDE EFFECTS

Like all medicines, HyperiTab can have side effects, although not everybody gets them. These are listed with as follows:

If you get any side effects, talk to your doctor, pharmacist or qualified healthcare practitioner. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store.

By reporting side effects you can help provide more information on the safety of this medicine.

5. HOW TO STORE HYPERITAB

Keep out of the reach and sight of children.

Do not use HyperiTab after the expiry date which is stated on the carton/blister strip. The expiry date refers to the last day of that month. Do not store above 25ºC. Store in the original container.

Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment.

6. FURTHER INFORMATION

What HyperiTab contains

Each film-coated tablet contains 313mg of extract (as dry extract) from St. John’s Wort aerial parts (Hypericum perforatum L.) (equivalent to 1000mg to 1500mg of St. John’s Wort). Extraction solvent: Methanol 80% v/v. The other ingredients are

Dicalcium phosphate anhydrous, Microcrystalline cellulose PH102, Croscarmellose sodium, Magnesium stearate, Hypromellose, Lactose and Colloidal anhydrous silica.

What HyperiTab looks like and contents of the pack

Clear dark purple brown, mottled oval film-coated tablets. The product is available in blister packs of 30 tablets and bottles of 45 tablets. Not all pack sizes may be marketed.

THR 12034/0027

THR holder and manufacturer

Quest Vitamins Limited

Gooses Foot Estate, Kingstone,

Hereford, HR2 9HY, United Kingdom

Telephone: +44 121 359 0056

This leaflet was updated on 25/11/2018.

For large print, braille or audio version of leaflet contact +44 121 359 0056 HyperiTab Package Leaflet: Information For The User

St John's Wort Extract 313mg

Certification Mark

About this document

Source: MHRA - Medicines and Healthcare products Regulatory Agency (products.mhra.gov.uk) · Marketing authorisation: THR120340027

MHRA data as of 13 October 2026

Found a mistake? Tell us on the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Facts about Hyperitab

Excipients Dicalcium phosphate anhydrous, Microcrystalline Cellulose PH102, Croscarmellose Sodium, Magnesium stearate, Hypromellose, Lactose, Colloidal anhydrous silica
Shelf life 18 months
Storage Do not store above 25º. Store in the original container.
Drug group (ATC) Herbal medicinal product for the treatment of depressive disorders
Marketing authorisation THR 12034/0027 (first authorised 4 March 2019)
Marketing authorisation holder Quest Vitamins Limited

Sources: the MHRA product information (products.mhra.gov.uk). Contains public sector information licensed under the Open Government Licence v3.0.